Current advances of Pichia pastoris as cell factories for production of recombinant proteins

(syn. spp.) has attracted extensive attention as an efficient platform for recombinant protein (RP) production. For obtaining a higher protein titer, many researchers have put lots of effort into different areas and made some progress. Here, we summarized the most recent advances of the last 5 years...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in microbiology 2022-11, Vol.13, p.1059777
Main Authors: Pan, Yingjie, Yang, Jiao, Wu, Jianping, Yang, Lirong, Fang, Hao
Format: Article
Language:English
Subjects:
CRISPR/Cas9
metabolic engineering
Microbiology
modeling
Pichia pastoris
recombinant protein
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:(syn. spp.) has attracted extensive attention as an efficient platform for recombinant protein (RP) production. For obtaining a higher protein titer, many researchers have put lots of effort into different areas and made some progress. Here, we summarized the most recent advances of the last 5 years to get a better understanding of its future direction of development. The appearance of innovative genetic tools and methodologies like the CRISPR/Cas9 gene-editing system eases the manipulation of gene expression systems and greatly improves the efficiency of exploring gene functions. The integration of novel pathways in microorganisms has raised more ideas of metabolic engineering for enhancing RP production. In addition, some new opportunities for the manufacture of proteins have been created by the application of novel mathematical models coupled with high-throughput screening to have a better overview of bottlenecks in the biosynthetic process.
ISSN:1664-302X
1664-302X
DOI:10.3389/fmicb.2022.1059777